文献速递胸部肿瘤

早期肺腺癌中TTF-1状态是独立于肿瘤分级的复发和生存预测因子且优于肿瘤分级

TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor grading.
PubMed 文献 · Eur J Cancer · 2023-12-10

该研究分析德国柏林和科隆两中心447例切除的肺腺癌(LUAD)患者,评估甲状腺转录因子1(TTF-1)状态与肿瘤分级的预后价值。单因素和多因素Cox回归显示TTF-1阳性与显著更长的无病生存(DFS)相关,且独立于包括分级在内的其他参数。作者推荐将TTF-1状态纳入LUAD诊断指南作为预后因素。

要点

  • 多因素分析中TTF-1阳性与显著更长的DFS相关(中位log HR -0.65;p=0.05),独立于肿瘤分级。
  • 肿瘤分级的预后作用仅限于TTF-1阳性患者,且TTF-1的效应量超过肿瘤分级。
  • 作者推荐将TTF-1状态作为预后因素纳入LUAD诊断指南。

核心结论

  • TTF-1状态独立于肿瘤分级预测LUAD的复发和生存,其效应量超过肿瘤分级。
  • 肿瘤分级的预后作用仅限于TTF-1阳性患者。
  • 作者推荐将TTF-1状态作为预后因素纳入LUAD诊断指南。

研究设计与样本

  • 研究纳入德国柏林和科隆主要肺癌中心447例切除的LUAD患者,分析TTF-1状态和分级与临床、病理及分子数据及患者结局的相关性。
  • 通过单因素和多因素Cox回归评估TTF-1的影响,并使用因果图分析识别和校正潜在混杂因素。

主要发现

  • 单因素分析显示TTF-1阳性与显著更长的DFS相关(中位log HR -0.83;p=0.018)。
  • 多因素分析中TTF-1阳性导致显著更长的DFS(中位log HR -0.65;p=0.05),独立于包括分级在内的所有其他参数。
  • 按因果图校正潜在混杂因素后证实TTF-1在预后能力上优于肿瘤分级。

临床怎么用

  • 作者推荐将TTF-1状态作为预后因素纳入LUAD诊断指南。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Thyroid transcription factor 1 (TTF-1) is a well-established independent prognostic factor in lung adenocarcinoma (LUAD), irrespective of stage. This study aims to determine if TTF-1's prognostic impact is solely based on histomorphological differentiation (tumor grading) or if it independently relates to a biologically more aggressive phenotype. We analyzed a large bi-centric LUAD cohort to accurately assess TTF-1's prognostic value in relation to tumor grade. PATIENTS AND METHODS: We studied 447 patients with resected LUAD from major German lung cancer centers (Berlin and Cologne), correlating TTF-1 status and grading with clinical, pathologic, and molecular data, alongside patient outcomes. TTF-1's impact was evaluated through univariate and multivariate Cox regression. Causal graph analysis was used to identify and account for potential confounders, improving the statistical estimation of TTF-1's predictive power for clinical outcomes. RESULTS: Univariate analysis revealed TTF-1 positivity associated with significantly longer disease-free survival (DFS) (median log HR -0.83; p = 0.018). Higher tumor grade showed a non-significant association with shorter DFS (median log HR 0.30; p = 0,62 for G1 to G2 and 0.68; p = 0,34 for G2 to G3). In multivariate analysis, TTF-1 positivity resulted in a significantly longer DFS (median log HR -0.65; p = 0.05) independent of all other parameters, including grading. Adjusting for potential confounders as indicated by the causal graph confirmed the superiority of TTF-1 over tumor grading in prognostics power. CONCLUSIONS: TTF-1 status predicts relapse and survival in LUAD independently of tumor grading. The prognostic power of tumor grading is limited to TTF-1-positive patients, and the effect size of TTF-1 surpasses that of tumor grading. We recommend including TTF1 status as a prognostic factor in the diagnostic guidelines of LUAD.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Schallenberg S, Dernbach G, Dragomir MP, et al. TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor grading. Eur J Cancer. 2023. PMID: 38100920. doi:10.1016/j.ejca.2023.113474

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。